Cigna Group Finalizes Sale of Medicare Businesses to HCSC
The Cigna Group, a prominent global health company, has successfully completed the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC). This strategic move marks an important step in streamlining The Cigna Group's portfolio, allowing the company to focus on innovation and better serve its customers.
Impact of the Transaction
With this divestment, The Cigna Group aims to allocate the proceeds in line with its capital deployment priorities, primarily directing funds towards share repurchases. This decision reinforces the company's commitment to enhancing shareholder value while also allowing it to concentrate on its core offerings.
Statements from Leadership
David M. Cordani, the Chairman and CEO of The Cigna Group, expressed pride in the significant impact their Medicare businesses have had on individuals' lives. He voiced confidence that HCSC would continue the meaningful work for these customers through the transition. Furthermore, Cordani emphasized their ongoing dedication to supporting Medicare populations via Evernorth Health Services, which will provide pharmacy benefits and other solutions to the Medicare businesses.
Future Goals and Commitment
HCSC's CEO, Maurice Smith, highlighted their mission of expanding access to quality healthcare across the United States. Smith noted the increasing health and wellness needs of older Americans, emphasizing their commitment to help seniors live healthier and fuller lives. With this acquisition, HCSC is excited to welcome new Medicare members and the dedicated employees supporting them.
Continuity of Care for Members
It's crucial for existing Medicare and CareAllies customers to know that this transaction will not disrupt their coverage or services. All elements of patient care will continue seamlessly, with customers still able to reach out with questions using the contact number on their member ID cards.
Advisors Involved in the Transaction
Centerview Partners LLC served as the financial advisor for The Cigna Group, while Morgan Stanley & Co. LLC provided additional financial guidance. The legal counsel for this transaction was provided by Wachtell, Lipton, Rosen & Katz. Regulatory counsel consisted of firms such as Rule Garza Howley LLP, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, and Sidley Austin LLP.
About The Cigna Group
The Cigna Group (NYSE: CI) operates as a global health company that is dedicated to creating a brighter future through the vitality of individuals and communities alike. The company is relentless in its mission to partner and innovate health solutions, delivering products and services marketed under the Cigna Healthcare and Evernorth Health Services brands. With operations in more than 30 markets and approximately 182 million customer relationships worldwide, The Cigna Group aims to shape a healthier society.
Frequently Asked Questions
What businesses has The Cigna Group sold?
The Cigna Group has sold its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to HCSC.
What is the purpose of this sale?
The sale is aimed at streamlining The Cigna Group's portfolio and allowing for further innovation to support customers.
How will the proceeds from the sale be used?
Proceeds from the sale will primarily be allocated to share repurchases, aligning with the company’s capital deployment priorities.
Will there be any disruption in services for existing customers?
No, there is no expected disruption in coverage or services for customers of the Medicare or CareAllies businesses.
Who were the advisors involved in this sale?
Centerview Partners LLC acted as the financial advisor, while Wachtell, Lipton, Rosen & Katz provided legal counsel. Other firms also helped with regulatory counsel.
